RxDoctor Payments Data

Chung-Che Chang, MD

Anatomic Pathology & Clinical Pathology · Orlando, FLNPI 1194773663

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $21,437 of the $25,064 with a category attached, or 85.5%. AstraZeneca accounts for 73.9% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $8,354 and has fallen 62.7% since, to $3,119 in 2025. Among anatomic pathology & clinical pathology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$25,064in general payments, 2019–2025

Across 40 payments — averaging $626.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$19K
  • Adaptive Biotechnologies Corporation$3K
  • Incyte Corporation$2K
  • BD$1K
  • Illumina, Inc.$282
  • Pillar Biosciences, Inc$126
  • plus $397 from 4 others

What the payments were for

  • Consulting fees$21,43786%
  • Travel & lodging$1,7217%
  • Food & beverage$1,9068%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca9$18,521
Adaptive Biotechnologies Corporation15$3,114
Incyte Corporation3$1,607
BD2$1,017
Illumina, Inc.5$282
Pillar Biosciences, Inc1$126
Astellas Pharma US Inc1$125
Boehringer Ingelheim1$122
Medline Industries LP2$84
Stemline Therapeutics Inc.1$67

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,064 in reported general payments places this provider in the 95th percentile of 510 anatomic pathology & clinical pathology providers in Florida.

See all anatomic pathology & clinical pathology providers in Florida

Medicare billing

Part B allowed, 2024
$45,569
Medicare patients
422
Services billed
1,145

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →